Where does Imagion Biosystems, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Imagion Biosystems, Inc. ranks #35,825 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Imagion Biosystems, Inc. hold?

Imagion Biosystems, Inc. holds 7 US utility patents granted between 2018 and 2024, spanning 6 technology areas.

What is Imagion Biosystems, Inc.'s Innovation Score?

Imagion Biosystems, Inc. has an Innovation Score of 27.8 out of 100 (25th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Imagion Biosystems, Inc. focus on?

Imagion Biosystems, Inc.'s top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 4 patents, ranking #3,645 of 7,127 assignees active in that subclass. Grants appear in 6 CPC subclasses total.

Is Imagion Biosystems, Inc.'s patent grant rate increasing or decreasing?

Imagion Biosystems, Inc.'s recent grant velocity is +33% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for Imagion Biosystems, Inc.'s patents?

Imagion Biosystems, Inc.'s patents average 14.3 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Imagion Biosystems, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Imagion Biosystems, Inc.

USPTO PatentsView assignee record - 7 granted patents across 6 technology areas, recorded in grant years 2018–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Imagion ranks #35,825 of 49,997 tracked US assignees by granted-patent volume, with 7 patents across 6 technology areas.

#35,825
of 49,997 US assignees by volume: 25th percentile
by Innovation Score (27.8/100): 14.3
avg claims per patent: +33%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R35825 · US Corporation #35,825 · 7 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-UP · BOOK-FULL

GRANTS-MICRO 7 grants
MID-PACK #35,825/49,997
PHOTO-FINISH Image Metrics
CPC-NARROW A61B · 6 areas
INNOV-THIN 27.8/100
CLAIMS-RICH 14.3 claims/avg
TYPE-USCORP US Corporation
VEL-UP +33% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Image Metrics, Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Imagion’s 27.8 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 7.2 pts (26%) Velocity 3.3 pts (12%) Breadth 8.7 pts (31%) Claim depth 8.6 pts (31%)

Qualcomm Incorporated · highest

85
Imagion Biosystems · this assignee

28
3D Lighting… · lowest

7

What this shows Imagion's Innovation Score is 27.8/100 (25th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Imagion?

Each dot is one of Imagion’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Imagion’s own 14.3 claims/patent is at or below the 14.3 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Imagion vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Imagion's grants concentrate

Imagion Biosystems, Inc. is a focused PatentsView assignee: 6 CPC subclasses with 57.1% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2019 (2 grants) versus a trough of 1 in 2018. By volume, Imagion sits between Image Metrics, Ltd. and Impeto Medical.

Imagion's three-year grant acceleration

Imagion Biosystems, Inc. shows 2 grants in 2022–2024 against only 4 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Image Metrics

7
Imagistar

7
Imagineering Plus…

7
Imaging Business…

7
Imatrex

7
Immersivetouch

7
Impact IP

7
Impeto Medical

7
Imagion Biosystems ◀

7

What this shows Imagion holds 7 patents at rank #35,906, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Imagion

By rank, the assignees closest to #35,906 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Imagion's primary technology class.

Imagion's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

28 25th percentile higher than 25% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2018–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.

View data table

Imagion Biosystems, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2018	1	14.3%
2019	2	28.6%
2021	2	28.6%
2023	1	14.3%
2024	1	14.3%

Which technologies does Imagion Biosystems, Inc. patent most?

A61B - DIAGNOSIS; SURGERY; Identification 4

G01R - Measuring Electric VARIABLES; Measuring Magnetic Variables 3

B03C - Magnetic OR Electrostatic Separation OF Solid Materials From Solid Materials OR FLUIDS; Separation BY High-voltage Electric Fields 3

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 3

C07K - Peptides 1

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 1

Top 6 of 6 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Imagion Biosystems, Inc.'s patent record in context - here's where to go next.

Imagion Biosystems, Inc.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 57.1% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #35,825 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Imagion Biosystems, Inc. against Image Metrics, Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 27.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.